M&A deal

Merger and acquisition consolidation, common in many industries, has slowed for health care in 2024 due to multiple factors, writes Shawn Janus, national director of health care services for Colliers. The economics were strained as increased interest rates, the resulting capital costs, increased regulatory scrutiny, and a slower-than-expected pandemic recovery made large transactions harder to finance. However, a few fundamental factors will likely drive M&A activity in the sector through 2025.

Health care M&A deal volume dropped 20% between 2023 and 2024. Total deal values were down 29% year-over-year. Deal volume and value fell respectively by 18% and 31% in the pharmaceutical and life sciences sectors. Health care services saw year-over-year drops of 22% in volume and 21% in value.


NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2025 ALM Global, LLC. All Rights Reserved.